363414184	363414184	CD	B-NP	O
|	|	NN	I-NP	O
KH	KH	NN	I-NP	O
|	|	NN	I-NP	O
09148500	09148500	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0296000	0296000	CD	B-NP	O
|	|	CC	I-NP	O
1/9/2005	1/9/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
NSTEMI	NSTEMI	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/9/2005	1/9/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/20/2005	4/20/2005	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
RUDLONG	RUDLONG	NN	B-NP	O
,	,	,	O	O
NUMBERS	NUMBERS	NN	B-NP	O
381-29-16-9	381-29-16-9	CD	I-NP	O
Chie	Chie	NNP	I-NP	O
Sa	Sa	NNP	I-NP	O
Sterlo	Sterlo	NNP	I-NP	O
Van	Van	NNP	I-NP	O
S	S	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
4/4/05	4/4/05	CD	B-NP	O
AT	AT	NN	I-NP	O
08	08	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
7pm	7pm	NN	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
lovenox	lovenox	NN	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BRUNECZ	BRUNECZ	NNP	B-NP	O
,	,	,	O	O
JULIAN	JULIAN	NNP	B-NP	O
G.	G.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NN	B-NP	B-protein
325	325	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/12/05	6/12/05	CD	B-NP	O
by	by	IN	B-PP	O
GANGLUFF	GANGLUFF	NN	B-NP	B-protein
,	,	,	O	O
CHONG	CHONG	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
788331387	788331387	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
needs	need	VBZ	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/26/05	6/26/05	CD	B-NP	O
by	by	IN	B-PP	O
IMHOLTE	IMHOLTE	NNP	B-NP	O
,	,	,	O	O
RENE	RENE	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
768390936	768390936	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/26/05	6/26/05	CD	B-NP	O
by	by	IN	B-PP	O
BROGAN	BROGAN	NNP	B-NP	O
,	,	,	O	O
KARL	KARL	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
122012248	122012248	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ATENOLOL	ATENOLOL	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/20/05	6/20/05	CD	B-NP	O
by	by	IN	B-PP	O
FOOR	FOOR	NN	B-NP	B-protein
,	,	,	O	O
RAY	RAY	NNP	B-NP	O
F.	F.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
needs	need	VBZ	B-VP	O
NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	O
0.4	0.4	CD	B-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
q5min	q5min	NN	I-NP	O
x	x	SYM	B-NP	O
3	3	CD	I-NP	O
PRN	PRN	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/12/05	6/12/05	CD	B-NP	O
by	by	IN	B-PP	O
MCDUFFEY	MCDUFFEY	NNP	B-NP	O
,	,	,	O	O
BRYANT	BRYANT	NNP	B-NP	O
N.	N.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
needs	need	VBZ	B-VP	O
LOVENOX	LOVENOX	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ENOXAPARIN	ENOXAPARIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
90	90	CD	I-NP	O
MG	MG	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/4/05	4/4/05	CD	B-NP	O
by	by	IN	B-PP	O
GAUDIOSO	GAUDIOSO	NN	B-NP	O
,	,	,	O	O
SHAWN	SHAWN	NNP	B-NP	O
V.	V.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
HEPARIN	HEPARIN	NNP	B-NP	O
&	&	CC	I-NP	O
ENOXAPARIN	ENOXAPARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
FLOVENT	FLOVENT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
110	110	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/12/05	6/12/05	CD	B-NP	O
by	by	IN	B-PP	O
HIPKINS	HIPKINS	NN	B-NP	B-protein
,	,	,	O	O
TYRON	TYRON	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
788331387	788331387	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
needs	need	VBZ	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/26/05	6/26/05	CD	B-NP	O
by	by	IN	B-PP	O
KEMPT	KEMPT	NN	B-NP	B-protein
,	,	,	O	O
BORIS	BORIS	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
QPM	QPM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
768390936	768390936	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/26/05	6/26/05	CD	B-NP	O
by	by	IN	B-PP	O
LAKIN	LAKIN	NN	B-NP	B-protein
,	,	,	O	O
IRWIN	IRWIN	NNP	B-NP	O
N.	N.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
122012248	122012248	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Tomorrow	Tomorrow	NNP	I-NP	O
May	May	NNP	I-NP	O
MAGNESIUM	MAGNESIUM	NNP	I-NP	O
OXIDE	OXIDE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
241	241	CD	I-NP	O
MG	MG	NNP	I-NP	O
ELEMENTAL	ELEMENTAL	NNP	I-NP	O
MG	MG	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
800	800	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Fluid	Fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
RETURN	RETURN	NN	I-NP	O
TO	TO	NN	I-NP	O
WORK	WORK	NN	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Campolongo	Campolongo	NNP	I-NP	O
within	within	IN	B-PP	O
4	4	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
PCP	PCP	NN	B-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
9/25/05	9/25/05	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
HWMH	HWMH	NN	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
acute	acute	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
NSTEMI	NSTEMI	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CHF	CHF	NNP	I-NP	O
CAD	CAD	NNP	I-NP	O
OPERATIONS	OPERATIONS	NNPS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNPS	I-NP	O
:	:	:	O	O
Catheterization	Catheterization	NN	B-NP	O
:	:	:	O	O
R	R	NN	B-NP	O
dominant	dominant	JJ	I-NP	O
,	,	,	I-NP	O
ostial	ostial	JJ	I-NP	O
OM1	OM1	NN	I-NP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
culprit	culprit	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
stented	stente	VBD	B-VP	O
with	with	IN	B-PP	O
2.5x13-mm	2.5x13-mm	JJ	B-NP	O
DES	DES	NNP	I-NP	O
;	;	:	O	O
diffuse	diffuse	JJ	B-NP	O
OM2	OM2	NN	I-NP	O
70	70	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
stented	stente	VBD	B-VP	O
with	with	IN	B-PP	O
2.5x13-mm	2.5x13-mm	JJ	B-NP	O
DES	DES	NNP	I-NP	O
;	;	:	O	O
and	and	CC	O	O
LCX	LCX	NN	B-NP	O
lesion	lesion	NN	I-NP	O
stented	stente	VBD	B-VP	O
with	with	IN	B-PP	O
3.5x13-mm	3.5x13-mm	JJ	B-NP	O
DES	DES	NNP	I-NP	O
,	,	,	O	O
all	all	DT	B-NP	O
stented	stente	VBD	B-VP	O
to	to	TO	B-PP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
TIMI	TIMI	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
flow	flow	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
ID/CC	ID/CC	NN	B-NP	O
:	:	:	O	O
68	68	CD	B-NP	O
yo	yo	NN	I-NP	O
retired	retire	VBD	B-VP	O
social	social	JJ	B-NP	O
worker	worker	NN	I-NP	O
with	with	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
of	of	IN	B-PP	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	O	O
possible	possible	JJ	B-NP	O
family	family	NN	I-NP	O
history	history	NN	I-NP	O
admitted	admit	VBN	B-VP	O
with	with	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
ACS	ACS	NN	B-NP	O
.	.	.	O	O

HPI	HPI	LS	B-LST	B-cell_type
:	:	:	O	O
Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
fairly	fairly	RB	B-ADJP	O
inactive	inactive	JJ	I-ADJP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
but	but	CC	B-PP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
had	have	VBD	B-VP	O
noted	note	VBN	I-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
with	with	IN	B-PP	O
walking	walk	VBG	B-VP	O
even	even	RB	B-NP	O
a	a	DT	I-NP	O
few	few	JJ	I-NP	O
steps	step	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
night	night	NN	B-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
severe	severe	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
breathe	breathe	VB	I-VP	O
in	in	IN	B-PP	O
comfortably	comfortably	RB	B-VP	O
even	even	RB	I-VP	O
sitting	sit	VBG	I-VP	O
bolt	bolt	NN	B-NP	O
upright	upright	NN	I-NP	O
;	;	:	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
accompanied	accompany	VBN	I-VP	O
by	by	IN	B-PP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	O	O
profuse	profuse	NN	B-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
XMC	XMC	NN	B-NP	O
clinic	clinic	NN	I-NP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
morning	morning	NN	I-NP	O
reporting	report	VBG	B-VP	O
the	the	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
:	:	SYM	I-NP	O
1	1	CD	I-NP	O
block	block	NN	I-NP	O
and	and	CC	O	O
2-3mm	2-3mm	JJ	B-NP	O
lateral	lateral	JJ	I-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
V4-V6	V4-V6	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
first	first	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
showed	show	VBD	B-VP	O
new	new	JJ	B-NP	O
deep	deep	JJ	I-NP	O
,	,	,	I-NP	O
symmetrical	symmetrical	JJ	I-NP	O
T-wave	T-wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
V4-V6	V4-V6	NN	B-NP	O
,	,	,	O	O
1-mm	1-mm	NN	B-NP	O
concave	concave	VBP	B-VP	O
down	down	RP	B-PRT	O
ST	ST	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
in	in	IN	B-PP	O
lead	lead	NN	B-NP	O
III	III	CD	I-NP	O
and	and	CC	O	O
similar	similar	JJ	B-NP	O
contour	contour	NN	I-NP	O
in	in	IN	B-PP	O
II	II	CD	B-NP	O
and	and	CC	O	O
aVF	aVF	NN	B-NP	O
although	although	IN	B-SBAR	O
not	not	RB	O	O
elevated	elevate	VBN	B-VP	O
.	.	.	O	O

First	First	JJ	B-NP	O
TnI	TnI	NNP	I-NP	O
7.39	7.39	CD	I-NP	O
,	,	,	O	O
MB	MB	NN	B-NP	B-cell_line
21.2	21.2	CD	I-NP	I-cell_line
.	.	.	O	O

Went	Went	JJ	B-ADJP	O
to	to	TO	B-PP	O
cath	cath	NN	B-NP	B-protein
lab	lab	NN	I-NP	I-protein
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
active	active	JJ	B-NP	O
thrombus	thrombus	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
OM	OM	NN	I-NP	O
distribution	distribution	NN	I-NP	O
;	;	:	O	O
received	receive	VBD	B-VP	O
drug-eluting	drug-eluting	JJ	B-NP	O
stents	stent	NNS	I-NP	O
to	to	TO	B-PP	O
OM1	OM1	NN	B-NP	B-protein
,	,	,	O	O
OM2	OM2	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
LCX	LCX	NN	B-NP	B-protein
and	and	CC	O	O
monitored	monitor	VBN	B-VP	O
overnight	overnight	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	B-DNA
with	with	IN	B-PP	O
18	18	CD	B-NP	O
hours	hour	NNS	I-NP	O
of	of	IN	B-PP	O
post-procedure	post-procedure	JJ	B-NP	O
eptifibatide	eptifibatide	NN	I-NP	O
.	.	.	O	O

Home	Home	NN	B-NP	O
meds	med	NNS	I-NP	O
:	:	:	O	O
metoprolol	metoprolol	NN	B-NP	O
,	,	,	O	O
norvasc	norvasc	NN	B-NP	O
,	,	,	O	O
combivent	combivent	JJ	B-NP	O
PEx	PEx	NNP	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
floor	floor	NN	B-NP	O
,	,	,	O	O
exam	exam	NN	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
faint	faint	JJ	B-NP	O
bibasilar	bibasilar	JJ	I-NP	O
crackles	crackle	NNS	I-NP	O
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
14	14	CD	I-NP	I-protein
,	,	,	O	O
S1S2	S1S2	NN	B-NP	O
intermittent	intermittent	NN	I-NP	O
gallop	gallop	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
with	with	IN	B-PP	O
variable	variable	JJ	B-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
bifascicular	bifascicular	JJ	B-NP	O
block	block	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LAFB	LAFB	NN	I-NP	O
and	and	CC	O	O
RBBB	RBBB	NN	B-NP	B-protein
-RRB-	-RRB-	NNP	I-NP	O
Assessment	Assessment	NNP	I-NP	O
and	and	CC	O	O
Hospital	Hospital	NNP	B-NP	O
Course	Course	NNP	I-NP	O
:	:	:	O	O
68	68	CD	B-NP	O
yo	yo	NN	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
non-ST	non-ST	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
with	with	IN	B-PP	O
variable	variable	JJ	B-NP	O
block	block	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
facilitated	facilitate	VBD	B-VP	O
PCI	PCI	NN	B-NP	B-protein
with	with	IN	B-PP	O
3	3	CD	B-NP	O
stents	stent	NNS	I-NP	O
in	in	IN	B-PP	O
OM	OM	NN	B-NP	O
and	and	CC	I-NP	O
LCX	LCX	NN	I-NP	O
distribution	distribution	NN	I-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CV	CV	NNP	I-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
s/p	s/p	NN	B-NP	O
NSTEMI	NSTEMI	NN	I-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
clopidogrel	clopidogrel	NN	B-NP	O
,	,	,	O	O
atorvastatin	atorvastatin	NN	B-NP	O
80	80	CD	I-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
100	100	CD	I-NP	O
,	,	,	O	O
captopril	captopril	NN	B-NP	O
converted	convert	VBD	B-VP	O
to	to	TO	I-VP	O
lisinopril	lisinopril	VB	I-VP	O
.	.	.	O	O

Pump	Pump	NNP	B-NP	O
:	:	:	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
and	and	CC	O	O
ACS	ACS	VBZ	B-VP	O
the	the	DT	B-NP	O
likely	likely	JJ	I-NP	O
precipitants	precipitant	NNS	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-NP	O
required	require	VBN	I-NP	O
O2	O2	NN	I-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
sat	sat	NN	B-NP	B-protein
>	>	JJR	B-NP	O
90	90	CD	I-NP	O
but	but	CC	O	O
gradually	gradually	RB	B-VP	O
titrated	titrate	VBN	I-VP	O
to	to	TO	B-PP	O
off	off	RB	B-ADVP	O
.	.	.	O	O

Diuresed	Diurese	VBN	B-VP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
80	80	CD	I-NP	O
IV	IV	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
negative	negative	JJ	B-NP	O
1	1	CD	I-NP	O
L/day	L/day	NNP	I-NP	O
for	for	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
and	and	CC	O	O
then	then	RB	B-VP	O
converted	convert	VBD	I-VP	O
to	to	TO	B-PP	O
PO	PO	NN	B-NP	B-protein
lasix	lasix	CD	I-NP	I-protein
40	40	CD	I-NP	I-protein
.	.	.	O	O

TTE	TTE	NN	B-NP	O
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
LV	LV	NN	I-NP	O
size	size	NN	I-NP	O
,	,	,	O	O
concentric	concentric	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
abnormal	abnormal	JJ	B-NP	O
septal	septal	JJ	I-NP	O
motion	motion	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
diffuse	diffuse	JJ	I-NP	O
HK	HK	NN	I-NP	O
.	.	.	O	O

Nl	Nl	NN	B-NP	B-protein
RV	RV	NN	I-NP	O
size/function	size/function	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
LAE	LAE	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
RAE	RAE	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
AI	AI	NN	I-NP	O
,	,	,	O	O
mild-mod	mild-mod	JJ	B-NP	B-protein
MR	MR	NN	I-NP	I-protein
,	,	,	O	O
mild	mild	JJ	B-NP	O
TR	TR	NN	I-NP	O
.	.	.	O	O

PA	PA	NN	B-NP	B-protein
29	29	CD	I-NP	I-protein
+	+	SYM	I-NP	O
RA	RA	NN	I-NP	O
.	.	.	O	O

Trace	Trace	NN	B-NP	O
pulmonic	pulmonic	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

Nutrition	Nutrition	NN	B-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
regarding	regard	VBG	B-PP	O
low-fat	low-fat	JJ	B-NP	O
and	and	CC	I-NP	O
low-salt	low-salt	JJ	I-NP	O
diets	diet	NNS	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
fluid	fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
Initially	Initially	RB	B-ADJP	O
rate-controlled	rate-controlled	JJ	I-ADJP	O
on	on	IN	B-PP	O
beta-blocker	beta-blocker	NN	B-NP	O
and	and	CC	I-NP	O
diltiazem	diltiazem	NN	I-NP	O
for	for	IN	B-PP	O
goal	goal	NN	B-NP	O
rate	rate	NN	I-NP	O
in	in	IN	B-PP	O
60s	60	NNS	B-NP	O
;	;	:	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
atenolol	atenolol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
QD	QD	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
several	several	JJ	B-NP	O
10-14-beat	10-14-beat	JJ	I-NP	O
runs	run	NNS	I-NP	O
of	of	IN	B-PP	O
NSVT	NSVT	NN	B-NP	B-protein
,	,	,	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
lyte	lyte	NN	I-NP	O
replacement	replacement	NN	I-NP	O
particularly	particularly	RB	B-ADVP	O
in	in	IN	B-PP	O
light	light	NN	B-NP	O
of	of	IN	B-PP	O
long	long	JJ	B-NP	O
QTc	QTc	NN	I-NP	O
.	.	.	O	O

Initiated	Initiate	VBN	B-NP	O
heparin	heparin	NN	I-NP	O
and	and	CC	O	O
discharged	discharge	VBN	B-VP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
lovenox	lovenox	NN	I-NP	O
bridge	bridge	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
considered	consider	VBN	I-VP	O
an	an	DT	B-NP	O
ICD	ICD	NN	I-NP	O
candidate	candidate	NN	I-NP	O
based	base	VBN	B-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
EF	EF	NN	I-NP	B-protein
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Endo	Endo	NNP	I-NP	O
:	:	:	O	O
PEHC	PEHC	NN	B-NP	O
chart	chart	NN	I-NP	O
shows	show	VBZ	B-VP	O
a	a	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
diabetes	diabete	NNS	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
fingersticks	fingerstick	NNS	I-NP	O
were	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
;	;	:	O	O
a	a	DT	B-NP	O
hemoglobin	hemoglobin	NN	I-NP	B-protein
A1C	A1C	NN	I-NP	O
was	be	VBD	B-VP	O
6.2	6.2	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Likely	Likely	RB	B-ADVP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
glucose	glucose	NN	B-NP	O
intolerance	intolerance	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
weight	weight	NN	B-NP	O
loss	loss	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
FEN	FEN	NNP	I-NP	O
:	:	:	O	O
Standing	Stand	VBG	B-VP	O
Mg	Mg	NN	B-NP	O
oxide	oxide	NN	I-NP	O
for	for	IN	B-PP	O
long	long	JJ	B-NP	O
QTc	QTc	NN	I-NP	O
;	;	:	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
800	800	CD	B-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
;	;	:	O	O
.	.	.	O	O

<	<	SYM	O	O
2g	2g	CD	B-NP	O
NaCl	NaCl	NN	I-NP	O
,	,	,	O	O
<	<	SYM	B-NP	O
2L	2L	NN	I-NP	O
Fluid	Fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
.	.	.	O	O

restricted	restricted	JJ	B-NP	O
,	,	,	I-NP	O
Cardiac	Cardiac	JJ	I-NP	O
diet	diet	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Renal	Renal	NNP	I-NP	O
:	:	:	O	O
Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
renal	renal	JJ	B-NP	O
arteries	artery	NNS	I-NP	O
were	be	VBD	B-VP	O
visualized	visualize	VBN	I-VP	O
during	during	IN	B-PP	O
catheterization	catheterization	NN	B-NP	O
;	;	:	O	O
study	study	NN	B-NP	O
revealed	reveal	VBD	B-VP	O
3	3	CD	B-NP	O
left	left	JJ	I-NP	O
renal	renal	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
,	,	,	O	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
2	2	CD	B-NP	O
right	right	JJ	I-NP	O
renal	renal	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
intervention	intervention	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
condition	condition	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
NH	NH	NN	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
service	service	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Take	Take	VB	B-VP	O
all	all	DT	B-NP	O
medicines	medicine	NNS	I-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
.	.	.	O	O

DO	DO	NN	B-NP	O
NOT	NOT	NN	I-NP	O
MISS	MISS	NN	I-NP	O
A	A	NN	I-NP	O
SINGLE	SINGLE	NN	I-NP	O
DOSE	DOSE	NN	I-NP	O
OF	OF	IN	B-PP	O
PLAVIX	PLAVIX	NN	B-NP	B-protein
.	.	.	O	O

THIS	THIS	VBZ	B-VP	O
MEDICINE	MEDICINE	NNP	B-NP	O
KEEPS	KEEPS	NNP	I-NP	O
YOUR	YOUR	NNP	I-NP	O
NEW	NEW	NNP	I-NP	O
STENTS	STENTS	NNP	I-NP	O
OPEN	OPEN	NNP	I-NP	O
AND	AND	NNP	I-NP	O
IS	IS	NNP	I-NP	O
VITALLY	VITALLY	NNP	I-NP	O
IMPORTANT	IMPORTANT	NNP	I-NP	O
TO	TO	NNP	I-NP	O
YOUR	YOUR	NNP	I-NP	O
HEALTH	HEALTH	NNP	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
GUM	GUM	NNP	B-NP	O
,	,	,	O	O
LAWRENCE	LAWRENCE	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TL49	TL49	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4/4/05	4/4/05	CD	I-NP	O
@	@	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
45	45	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

